Session Details
[S10]Development of vaccines against infectious diseases
Sat. Mar 27, 2021 3:45 PM - 5:45 PM JST
Sat. Mar 27, 2021 6:45 AM - 8:45 AM UTC
Sat. Mar 27, 2021 6:45 AM - 8:45 AM UTC
[Room C] Oral Presentation C Online
Organizer: Yoshioka Yasuo (OTRI, Osaka Univ.), Kunisawa Jun (NIBIOHN)
Vaccination is one of the most critical and reliable strategies to prevent severe illness and control the spread of infectious diseases at the population level. Several types of vaccines, such as attenuated live vaccines, inactivated whole vaccines, and protein-based subunit vaccines, will need to be developed when emerging infectious diseases arise. In addition, a rational choice of adjuvants is required for improving the potency of the protective immune response to vaccines. In this symposium, we will discuss about the development of novel vaccine against infectious diseases including COVID-19.
オーガナイザー挨拶：吉岡 靖雄（阪大先導、阪大微研、一財）阪大微研、阪大院薬、阪大MEI）
[S10-1]Development of a vaccine platform for emerging infectious diseases
○Yasuo Yoshioka1,2,3,4,5 (1. OTRI, Osaka Univ., 2. RIMD, Osaka Univ., 3. BIKEN, 4. Grad. Sch. of Pharm.l Sci., Osaka Univ., 5. MEI, Osaka Univ.)
[S10-2]Prediction of vaccine adverse reactions and development of peptide vaccine for COVID-19
○Hiroyuki Oshiumi1, Momoka Nakashima2, Atsushi Irie1 (1. Faculty of Life Sci., Kumamoto Univ., 2. Grad. Sch. Med. Sci., Kumamoto Univ.)
[S10-3]Current progress of the development of HIV, HTLV, and SARS-CoV-2 vaccines
○Tetsuro Matano1,2 (1. NIID/ARC, 2. IMSUT)
[S10-4]DNA/RNA vaccine platform based on the intracellular environment-responsive lipid-like material (ssPalm)
○Hidetaka Akita1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)
[S10-5]Control of immunological defense via gut environment for the development of vaccine and adjuvant
○Jun Kunisawa1 (1. NIBIOHN)